Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tiotropium Efficacy Against Allergen Induced Early Asthmatic Responses

NCT04648813 is registered in ClinicalTrials.gov with University of Saskatchewan as lead sponsor.

NCT NCT04648813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04648813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tiotropium Efficacy Against Allergen Induced Early Asthmatic Responses
Lead sponsor
University of Saskatchewan
Phase
Phase 4
Overall status
Completed
Start date
November 13, 2020
Completion date
April 20, 2021
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic asthma